How Often Should Women Take The Pap Smear Test?
Key highlights or summary
- The Pap smear test is a crucial screening for detecting precancerous and cell changes on the cervix.
- Women under 21 don't need screening, while those aged 21-29 should get tested every 3 years if results are normal.
- For women aged 30-64, a Pap smear every 3 years or a combined Pap and HPV test every 5 years is advised.
- Women aged 65 and above can usually skip screening if they have a history of normal results and have had a hysterectomy for non-cancerous conditions.
- Screening every 3 years, instead of annually, is now seen as sufficient.
- Getting a Pap smear during menstruation is possible, but it's better to reschedule to avoid influence on results.
- It's vital not to skip Pap tests. They are key in preventing cervical cancer
- Most sexually active individuals have HPV, often without knowing it. Regular Pap smears are essential for detecting HPV.
Rate our article
We'd love to know!
- Cohen, P. A., Jhingran, A., Oaknin, A., & Denny, L. (2019). Cervical cancer. The Lancet, 393(10167), 169-182.
- Perkins, R. B., Guido, R. S., Castle, P. E., Chelmow, D., Einstein, M. H., Garcia, F., ... & Schiffman, M. (2020). 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Journal of lower genital tract disease, 24(2), 102.
- Melnikow, J., Henderson, J. T., Burda, B. U., Senger, C. A., Durbin, S., & Soulsby, M. A. (2018). Screening for cervical cancer with high-risk human papillomavirus testing: a systematic evidence review for the US Preventive Services Task Force.
- Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health, 8(2), e191-e203.
- Petry, K. U. (2014). HPV and cervical cancer. Scandinavian Journal of Clinical and Laboratory Investigation, 74(sup244), 59-62.
- Wang, R., Pan, W., Jin, L., Huang, W., Li, Y., Wu, D., ... & Liao, S. (2020). Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer letters, 471, 88-102.
- Ruhl JL, Callaghan C, Hurlbut, A, Ries LAG, Adamo P, Dickie L, Schussler N (eds.) Summary Stage 2018: Codes and Coding Instructions, National Cancer Institute, Bethesda, MD, 2018.
How was the experience with article?
We'd love to know!